| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Association of Single Nucleotide Polymorphisms in STAT3 with Hand-Foot Skin Reactions in Patients with Metastatic Renal Cell Carcinoma Treated with Multiple Tyrosine Kinase Inhibitors: A Retrospective Analysis in Japanese Patients
|
Yamamoto, Kazuhiro
|
|
2015
|
11 |
1 |
p. 93-99
|
article
|
| 2 |
Author’s Reply to Christelle de la Fouchardière: “Regorafenib: Start Low and Go Slow”
|
Tabchi, Samer
|
|
2015
|
11 |
1 |
p. 127-128
|
article
|
| 3 |
Comment on: “Regorafenib: Start Low and Go Slow”
|
de la Fouchardière, Christelle
|
|
2015
|
11 |
1 |
p. 123-125
|
article
|
| 4 |
Does Molecular Genotype Provide Useful Information in the Management of Radioiodine Refractory Thyroid Cancers? Results of a Retrospective Study
|
Fouchardiere, Christelle de la
|
|
2015
|
11 |
1 |
p. 71-82
|
article
|
| 5 |
Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review
|
Ipenburg, Norbertus A.
|
|
2015
|
11 |
1 |
p. 17-27
|
article
|
| 6 |
Histone Deacetylase Inhibitors Resensitize EGFR/EGFRvIII-Overexpressing, Erlotinib-Resistant Glioblastoma Cells to Tyrosine Kinase Inhibition
|
Liffers, Katrin
|
|
2015
|
11 |
1 |
p. 29-40
|
article
|
| 7 |
HPMA Copolymer-Conjugated Pirarubicin in Multimodal Treatment of a Patient with Stage IV Prostate Cancer and Extensive Lung and Bone Metastases
|
Dozono, Haruhiko
|
|
2015
|
11 |
1 |
p. 101-106
|
article
|
| 8 |
Is There a Survival Benefit of First-Line Epidermal Growth Factor Receptor Tyrosine-Kinase Inhibitor Monotherapy Versus Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer?: A Meta-Analysis
|
Guetz, Gaetan Des
|
|
2015
|
11 |
1 |
p. 41-47
|
article
|
| 9 |
Lenvatinib: A Review in Refractory Thyroid Cancer
|
Frampton, James E.
|
|
2016
|
11 |
1 |
p. 115-122
|
article
|
| 10 |
Panobinostat: A Review in Relapsed or Refractory Multiple Myeloma
|
Greig, Sarah L.
|
|
2016
|
11 |
1 |
p. 107-114
|
article
|
| 11 |
RETRACTED ARTICLE: The Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Molecularly Selected Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of 30 Randomized Controlled Trials
|
Liu, Jin
|
|
2015
|
11 |
1 |
p. 49-58
|
article
|
| 12 |
Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort
|
Rouyer, Magali
|
|
2015
|
11 |
1 |
p. 83-92
|
article
|
| 13 |
Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles
|
Pistollato, Francesca
|
|
2015
|
11 |
1 |
p. 1-16
|
article
|
| 14 |
Vemurafenib pharmacokinetics and its correlation with efficacy and safety in outpatients with advanced BRAF-mutated melanoma
|
Kramkimel, N.
|
|
2015
|
11 |
1 |
p. 59-69
|
article
|
Journal description